Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?

Brothman, Arthur R; Swanson, Gregory; Maxwell, Teresa M; Cui, Jiang; Murphy, Kelley J; Herrick, Jennifer; Speights, V O; Isaac, Jorge; Rohr, L Ralph

Brothman, Arthur R; Swanson, Gregory; Maxwell, Teresa M; Cui, Jiang; Murphy, Kelley J; Herrick, Jennifer; Speights, V O; Isaac, Jorge; Rohr, L Ralph.

Affiliation

Brothman AR; Department of Pediatrics, University of Utah School of Medicine, 1C210 SOM, 30 North 1900 East, Salt Lake City, UT 84132-2117, USA. art.brothman@genetics.utah.edu

Cancer Genet Cytogenet ; 156(1): 31-6, 2005 Jan 01.

Article in En | MEDLINE | ID: mdl-15588853

Subject(s)

5-Methylcytosine/metabolism; Prostatic Neoplasms/metabolism; 5-Methylcytosine/immunology; Aged; DNA Methylation; Densitometry/methods; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Models, Biological; Prostatic Neoplasms/pathology; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / 5-Methylcytosine Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Cancer Genet Cytogenet Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links